. Analysis pipeline for somatic mutations, gene expression, RNA fusions, and copy number profiling in pediatric PDX tumors, Related to Figures 1-5. Figure S1 displays an overview of analysis methods utilized. Genomic DNA from PDX tumors was used for SNP array copy number analysis (A, N = 252), short-tandem repeat identity testing (B, N = 261), quantitative PCR to assess human:mouse DNA content (B, N = 35 samples with N = 3 technical replicates), and whole exome sequencing (C, N = 240). Total RNA from PDX tumors was used for whole transcriptome sequencing (D, N = 244). See Table S1 for Ns per assay per histology and Table S2 for STR profiles. Unless otherwise noted, Ns denote biological replicates.
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Log R Ratio With osteosarcoma models removed from analysis, TP53 classifier scores were still significantly higher (NWT = 180, NALT = 34, Wilcoxon p = 1e-11) in models with a TP53 alteration (A), but alterations in other pathway genes don't consistently phenocopy TP53 inactivation (B). Models containing fusions had highest classifier scores, followed by models with SNVs and CNVs, respectively (C, Kruskal-Wallis p = 9.8e-11, NWT = 120, NFUSIONS = 14, NSNV = 81, NCNV = 85). Post hoc Wilcoxon p-values and group comparisons are displayed. Panel D breaks down the data in C by gene. Validation of mutational signatures via Pearson correlation matrix: Signatures 2 and 13 correlate strongly (R = 0.6, p= 6.5e-25, N = 260), Signature 1 is inversely correlated with impaired DNA repair mutational signatures, 3 (R = -0.41, p = 3.29e-11 , N = 260) and 6 (R = -0.54, p = 8.12e-20, N = 260) (E). Hierarchical clustering depicts tissue-specific enrichment within each histology (F, N = 244, NES = normalized enrichment score). All Ns denote biological replicates. 
